Cargando…

Hereditary Angioedema with Normal C1 Esterase Inhibitor Refractory to Long-Term Prophylaxis: A Case Report

Hereditary angioedema (HAE) was classically thought to be related to a deficiency in the C1 esterase inhibitor (C1-INH). However, HAE with a normal C1 esterase inhibitor (HAE nC1-INH) is a rare disease that has been recently characterized. In this case, we describe a woman with a 21-year history of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cobb, Gavin, Bernabe, Celina C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931377/ https://www.ncbi.nlm.nih.gov/pubmed/36819342 http://dx.doi.org/10.7759/cureus.33800

Ejemplares similares

Angioedema in the Absence of C1 Esterase Inhibitor Deficiency in a Young Patient With Anti-dsDNA Negative Lupus Nephritis
por: Nadeem, Ifrah, et al.
Publicado: (2023)

Long-term prophylaxis of hereditary angioedema with danazol
por: Xu, Yingyang, et al.
Publicado: (2022)

Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor()
por: Jones, Douglas H., et al.
Publicado: (2022)

Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema
por: Riedl, Marc
Publicado: (2015)

Short-term Prophylaxis for Delivery in Pregnant Women with Hereditary Angioedema with Normal C1-Inhibitor
por: Moraes, Caroline Guth de Freitas Batista de, et al.
Publicado: (2020)

Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor
por: Jones, Douglas, et al.
Publicado: (2023)

The Interplay of COVID-19 and Hereditary Angioedema: Preventing an Acute Attack
por: Park, Erin G, et al.
Publicado: (2022)

The Price of a Life: Unveiling the Struggle of Living With Hereditary Angioedema
por: Welch, Nicole L, et al.
Publicado: (2023)

Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema
por: Craig, Timothy, et al.
Publicado: (2017)

Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children
por: Reshef, Avner, et al.
Publicado: (2019)

Plasma-derived C1 esterase inhibitor pharmacokinetics and safety in patients with hereditary angioedema
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2023)

Long-term prophylaxis for hereditary angioedema: Initial experiences with garadacimab and lanadelumab
por: Wong, Jane C.Y., et al.
Publicado: (2023)

Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies
por: Gower, Richard G, et al.
Publicado: (2011)

Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry()
por: Valerieva, Anna, et al.
Publicado: (2021)

Hereditary Angioedema
por: Banerjee, Anjali, et al.
Publicado: (2023)

Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries
por: Guo, Yinshi, et al.
Publicado: (2022)

Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema
por: Feussner, Annette, et al.
Publicado: (2014)

Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance
por: Li, Huamin Henry
Publicado: (2016)

The Search for Biomarkers in Hereditary Angioedema
por: Kaplan, Allen P., et al.
Publicado: (2017)

Pregnancy-Induced Exacerbation of Hereditary Angioedema in a Multiparous Caucasian Female
por: Sankrithi, Praveen, et al.
Publicado: (2020)

Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor
por: Bork, Konrad
Publicado: (2010)

Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor
por: Gabriel, Natalia, et al.
Publicado: (2022)

Hereditary Angioedema-Associated Acute Pancreatitis in C1-Inhibitor Deficient and Normal C1-Inhibitor Patients: Case Reports and Literature Review
por: Veronez, Camila Lopes, et al.
Publicado: (2019)

Acquired Non-histaminergic Angioedema With C1q Autoantibody and Urticaria: A Case Report
por: Kochvar, Andrew P, et al.
Publicado: (2023)

The First Occurrence of Angioedema After Discontinuation of Angiotensin-Converting Enzyme Inhibitor
por: Kainat, Aleesha, et al.
Publicado: (2021)

Multidisciplinary Prophylactic Strategies for Recurrence of Laryngeal Edema After Tooth Extraction in a Patient With Hereditary Angioedema: A Case Report
por: Honda, Daisuke, et al.
Publicado: (2023)

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
por: Agostoni, Angelo, et al.
Publicado: (2004)

Informed decision‐making in hereditary angioedema prophylaxis
por: Burnette, Autumn Ford
Publicado: (2021)

Mechanisms involved in hereditary angioedema with normal C1-inhibitor activity
por: Shamanaev, Aleksandr, et al.
Publicado: (2023)

A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema
por: Aygören‐Pürsün, Emel, et al.
Publicado: (2019)

Reviewing clinical considerations and guideline recommendations of C1 inhibitor prophylaxis for hereditary angioedema
por: Anderson, John, et al.
Publicado: (2022)

Recent developments in the treatment of acute abdominal and facial attacks of hereditary angioedema: focus on human C1 esterase inhibitor
por: Cardona, Lourdes Pastó, et al.
Publicado: (2010)

Hereditary Angioedema: The Economics of Treatment of an Orphan Disease
por: Lumry, William Raymond
Publicado: (2018)

Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema
por: Levy, Donald, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema With Resultant Airway Obstruction Following Endotracheal Intubation
por: Vazirnia, Parsia, et al.
Publicado: (2023)

Case report: follow-up of long term prophylaxis of hereditary angioedema with an alternative attenuated androgenic drug
por: Tebyrica, João
Publicado: (2015)

Prospective Study of Rapid Relief Provided by C1 Esterase Inhibitor in Emergency Treatment of Acute Laryngeal Attacks in Hereditary Angioedema
por: Craig, Timothy J., et al.
Publicado: (2010)

Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
por: Farkas, Henriette, et al.
Publicado: (2020)

Real-Life Experience With Subcutaneous Plasma-Derived C1-Inhibitor for Long-Term Prophylaxis in Patients With Hereditary Angioedema: A Case Series
por: Zanichelli, Andrea, et al.
Publicado: (2022)

Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor
por: McKibbin, Lundy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4r3fmvl9v29k0tvdj6ll5jfmfm